Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped up prior to trading on Friday . The stock had previously closed at $2.15, but opened at $2.28. Curaleaf shares last traded at $2.13, with a volume of 86,856 shares changing hands.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Zacks Research upgraded Curaleaf from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. ATB Cormark Capital Markets upgraded Curaleaf to an “outperform” rating in a report on Tuesday, December 2nd. Finally, Alliance Global Partners reissued a “buy” rating on shares of Curaleaf in a research report on Monday, December 22nd. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Curaleaf currently has a consensus rating of “Buy”.

Curaleaf Stock Performance

The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of -7.22 and a beta of 0.71. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.76 and a current ratio of 1.52. The stock’s fifty day moving average is $2.36 and its two-hundred day moving average is $2.61.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $333.07 million during the quarter, compared to analysts’ expectations of $328.70 million. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%. Analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.